Anzeige
Mehr »
Lynx Broker
Login
Freitag, 23.08.2019 Börsentäglich über 12.000 News von 607 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Zur alten Webversion

Aktuelle News von Endpoints News

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
10:35GSK's Hal Barron heralds their second positive PhIII for crucial anti-BCMA therapy, pointing to a push for quick OKs in a crowded field
DoBiotech leaders rally behind Chinese scientists in US, calls for 'measured' policies in wake of purges
DoAmgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study
DoBeiGene and Mustang nail down special FDA status for top drugs; Roche bags added coverage for Hemlibra
DoTrump administration revives bid to get drug list prices on TV ads
DoGet as much Spravato as you can, Trump orders VA while suggesting J&J should offer it to veterans for free
DoAn emboldened AstraZeneca splurges $95M on a priority review voucher. Where do they need the FDA to hustle up?
DoVersant-backed Chinook gets a $65M launch round for its discovery quest in a resurgent kidney field
DoSir Andrew Dillon, NICE's first - and only - chief executive to step down next year
DoEight weeks between each HIV treatment? GSK notches PhIII win as it chases OK for long-acting regimen
DoPrisoner #87850-053 does not get to add drug developer to his list of credits
DoFinch grabs a $53M round designed to take their 'breakthrough' microbiome treatment through a potentially pivotal trial
DoVienna-based vaccine developer Themis signs pact with Merck for 'blockbuster indication'
MiSEC calls out little TherapeuticsMD for selective disclosure of FDA updates following CRL
MiGSK submits its first application for daprodustat in Japan; Two drugmakers part with $15M to avoid opioid trial
MiMDMA, now in Phase III, shows promise as a PTSD treatment
MiPfizer is making a $500M statement today: Here's how you become a lead player in the booming gene therapy sector
MiMHRA to land a new interim chief executive ahead of Brexit
MiVideo: Putting the AI in R&D - with Badhri Srinivasan, Tony Wood, Rosana Kapeller, Hugo Ceulemans, Saurabh Saha and Shoibal Datta
MiCowen, Perceptive lead $79.5M Series B for 'standout' biotech shepherding oncolytic virus to clinic
MiFutility analysis augurs defeat in pivotal trial testing of NuCana's lead drug in metastatic pancreatic cancer
MiAstraZeneca's Imfinzi/treme combo strikes out - again - in lung cancer. Is it time for last rites?
DiWebinar: Real World Endpoints - the brave new world coming in building franchise therapies
DiPfizer Foundation offers $2M in grants to NGOs tackling antimicrobial resistance; Biogen, Invitae join forces to develop faster SMA diagnostic
DiFDA decision on Vertex's CF triple will come just ahead of planned CEO shakeup